Literature DB >> 21618366

Varicella zoster meningoradiculitis in Crohn's disease treated with 6-mercaptopurine.

Garret Cullen, Douglas Krakower, Jennifer A Mitty, Adam S Cheifetz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618366      PMCID: PMC4822417          DOI: 10.1002/ibd.21782

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  6 in total

1.  Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus.

Authors:  C Springfeld; A Sauerbrei; A Filusch; M Konstandin; W Hartschuh; P Sauer; J Encke; W Stremmel; P Schnitzler
Journal:  J Clin Virol       Date:  2008-12-03       Impact factor: 3.168

2.  Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection.

Authors:  E Gold
Journal:  N Engl J Med       Date:  1966-01-27       Impact factor: 91.245

3.  Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine.

Authors:  D E Deutsch; A D Olson; S Kraker; C J Dickinson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1995-04       Impact factor: 2.839

4.  Fatal varicella-zoster virus meningoradiculitis without skin involvement.

Authors:  A N Dueland; M Devlin; J R Martin; R Mahalingam; R Cohrs; H Manz; I Trombley; D Gilden
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

Review 5.  The protean neurologic manifestations of varicella-zoster virus infection.

Authors:  Maria A Nagel; Donald H Gilden
Journal:  Cleve Clin J Med       Date:  2007-07       Impact factor: 2.321

Review 6.  Varicella-zoster virus latency in human ganglia.

Authors:  Peter G E Kennedy
Journal:  Rev Med Virol       Date:  2002 Sep-Oct       Impact factor: 6.989

  6 in total
  1 in total

Review 1.  Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease.

Authors:  Christopher Ma; Brennan Walters; Richard N Fedorak
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.